Memories of classical ballet performances dance in Wanda Sihanath's head when she thinks about her childhood in Elgin, Illinois. She remembers balancing at the barre to Beethoven and pirouetting to ...
Please provide your email address to receive an email when new articles are posted on . Thompson described beta-thalassemia as a severe chronic inherited blood disorder due to one of many mutations in ...
At the time of the interim analysis, 91.4% (32/35) of patients achieved transfusion independence for 12 consecutive months. The Food and Drug Administration (FDA) has approved Casgevy ™ (exagamglogene ...
A novel gene therapy promoted transfusion independence in more than 90 percent of adult and pediatric patients with transfusion-dependent beta-thalassemia, according to a recent clinical trial ...
All four parent studies are complete, and all patients have transitioned to a long-term follow-up study (LTF-303) SOMERVILLE, Mass.--(BUSINESS WIRE)--Updated data from bluebird bio inc.’s (NASDAQ: ...
Over 90 percent of patients with transfusion-dependent thalassemia, an inherited blood disorder, no longer needed monthly blood transfusions years after receiving gene therapy, according to an ...
Blood transfusion therapy remains an indispensable intervention in the management of sickle cell disease (SCD), mitigating life‐threatening complications such as vaso‐occlusive crises and stroke. The ...
KUWAIT CITY, Jan 19: Kuwaiti Health Minister Dr. Ahmad Al-Awadhi inaugurated the 15th Arab Conference on Transfusion Medicine ...
When hemoglobin concentration is less than 10g/dL, liberal red blood cell transfusion strategy is suggested. HealthDay News — A liberal red blood cell (RBC) transfusion strategy is suggested for ...
A novel gene therapy promoted transfusion independence in more than 90 percent of adult and pediatric patients with transfusion-dependent beta-thalassemia, according to a recent clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results